Pharma and proactive, preventative healthcare: how to use th...

Across Europe, a shift towards greater prevention, earlier diagnosis and treatment is needed in order to contain the growing cost of healthcare. This webinar hosted by pharmaphorum with sponsor PHOENIX group looks at how harnessing the data and expertise of pharmacies, and via greater engagement with patients, consumers and shoppers can meet this emerging need.

Disruption and maturity: the future directions for biologics

Is the UK’s NHS saving enough from the new wave of biosimilars?

Powering pharma’s commercial teams with market access insigh...

When small becomes big: orphan medicines, advances, access a...

Significant unmet need still remains in the rare disease market, only around 5% of rare diseases currently have an approved drug treatment. This represents a major opportunity for the pharmaceutical industry. Our webinar will assess the critical factors underpinning success in the rare disease space and provide a view into the future of market access and health technology assessments for orphan medicines – alongside the impact on R&D and clinical trials – in the context of Brexit negotiations.

Unlocking the value of pharmacists to reach the right patien...

Pharmacists are highly trained healthcare professionals who have a deep understanding of medicines and daily contact with patients and consumers, putting them in a unique position in terms of being able to maximise the benefits that patients get from their medicines. However, healthcare systems and pharmaceutical companies frequently overlook this potential.

Approval and access: overcoming the final hurdle of drug dev...

2017 is likely to be a year of significant change for pharma brands in Europe. With affordability on the agenda for almost every country in the region, a move toward greater collaboration in health